Tag: Pharmaceutical Industry

This image provided by Amag Pharmaceuticals in June 2019 shows packaging for their drug Vyleesi. The medication OK'd Friday by the U.S. Food and Drug Administration is only the second approved to increase sexual desire in a women.

Coming soon to US bedrooms: Injectable ‘female Viagra’

Kimberly Leonard · June 21, 2019 11:52 pm

In this Aug. 17, 2018 photo, family and friends who have lost loved ones to OxyContin and opioid overdoses leave pill bottles in protest outside the headquarters of Purdue Pharma, which is owned by the Sackler family, in Stamford, Conn. The Sackler familyâs ties to OxyContin and the painkillerâs role in the deadly opioid crisis are bringing the Sacklers a new kind of attention and complicating their philanthropic legacy.

World Health Organization removes guidelines downplaying opioid addiction risk after criticism from US legislators

Grayce McCormick · June 20, 2019 9:21 pm

Principal scientists Matt Drever, left, scrapes bacteria from an agar plate during an antibody phage experiment as principal scientist Charlie Holst watches.

Pfizer gains new cancer drugs in $11.4B purchase of Array BioPharma

James Langford · June 17, 2019 5:21 pm

FILE - In this March 13, 2019, file phtooHealth and Human Services Secretary Alex Azar testifies before a House Appropriations subcommittee on Capitol Hill in Washington. Azar says drugmakers will soon have to reveal prices of their prescription medicines in those ever-present TV ads. The Trump administration will issue final regulations on May 8 requiring drug companies to disclose list prices of medications costing more than $35 for a monthâs supply. Azar tells The Associated Press if drugmakers are scared to put prices in ads that means they should lower those prices.

Drugmakers sue to block Trump rule requiring drug prices in TV advertisements

Noah Garfinkel · June 14, 2019 9:56 pm

Medical marijuana and pill bottles.

Church suspends rules against marijuana investment

Ellie Bufkin · June 13, 2019 8:04 pm

Florida Gov. Ron DeSantis (center) speaks at an event.

Florida Governor Ron DeSantis breaks with GOP and signs drug importation bill

Cassidy Morrison · June 11, 2019 6:46 pm

Equality March for Unity and Pride participants march past the White House in Washington, Sunday, June 11, 2017.

Beltway Confidential

Trump isn’t sabotaging the fight against HIV — he’s leading it

Brad Polumbo · June 7, 2019 7:04 pm

Beltway Confidential

Trump team has the wrong twist on drug pricing policy

Quin Hillyer · June 7, 2019 5:41 pm

In this Jan. 30, 2019, file photo, Insys Therapeutics founder John Kapoor leaves federal court in Boston.

Drug manufacturer to pay $225 million to end opioid investigations

Zach Halaschak · June 6, 2019 12:46 am

Principal scientists Matt Drever, left, scrapes bacteria from an agar plate during an antibody phage experiment as principal scientist Charlie Holst watches.

Beltway Confidential

The new Right: Who needs innovation when you can stifle it?

Charles Sauer · May 24, 2019 6:25 pm

Sen. Patty Murray, D-Wash., the ranking member, and Sen. Lamar Alexander, R-Tenn., chairman of the Senate Health, Education, Labor, and Pensions Committee, meet before the start of a hearing on Capitol Hill in Washington, Wednesday, Oct. 18, 2017, the morning after they reached a deal to resume federal payments to health insurers that President Donald Trump had halted. Sen. Alexander says Trump called him Wednesday morning "to be encouraging" of bipartisan efforts to come up with a plan to stabilize health insurance premiums.

Alexander and Murray release wide-ranging bipartisan plan to lower healthcare costs

Cassidy Morrison · May 23, 2019 5:35 pm

Beltway Confidential

How Rembrandt and Degas could help end the opioid crisis

Madeline Fry Schultz · May 17, 2019 4:00 am